Our mission is to extend healthspan and lifespan with Cell Reset therapeutics.
Meet the Leadership Team
JOHN HOEKMAN
PhD, Co-founder & CEO
Founder, CSO, and CEO Impel Pharma. Brought his PhD invention to FDA approval for Trudhesa® for migraines. Inventor on >100 patents. PhD in Pharmaceutics at Univ. of Washington.
JANINE SENGSTACK
PhD, Co-founder & CSO
Inventor of RESET platform. Transcription factor, cell aging and bioinformatics expert. Hillblom Fellow. PhD in Cellular Aging at UCSF.
YI JIN
PhD, VP of siRNA Therapeutic Development
20 years of siRNA experience. Previously, Scientific Director of siRNA of Johnson & Johnson Innovative Medicine.
ROB CAHILL
Co-founder, COO & CBO
UCSF Bioinformatics & Machine Learning. Founder & CEO at Jhana, acquired by FranklinCovey (NYSE: FC). EVP Product & Client Success at FranklinCovey. McKinsey. Stanford.
Our Team
CHARU REDDY
PhD, Principal Scientist, Preclinical
10+ years in metabolism and preclinical biotech. Postdoc at Harvard Medical School. PhD in rodent metabolism.
MOLLY KAEDING
Scientist, Early Discovery
Scientist roles at Nkarta, NASA, Stanford. MS/BS Biochemistry/Bio.
JIASHUN ZHENG
PhD, Bioinformatics Data Science
UCSF Professional Researcher. Collaborator, co-inventor and co-lead author
with Dr. Sengstack and Dr. Li.
CARLEY HENDRIKS
Scientist, Early Discovery
RNA scientist. 18th employee at Mammoth Biosciences. BS Biochemistry.
L’ERIN MOORE
Scientist, Preclinical
10+ years of preclinical research at Gilead and Northwestern University.
SETH PAULSON
Software Engineer, AI Platform
15 years of full-stack software development. Creator and lead developer at Biolearn, open source library for biomarkers of aging.
ALYSSA AMEZQUITA
Research Associate, Early Discovery
Research roles at GigaMune, Scribe Biosciences and Saeij Lab of the Pathology, Microbiology and Immunology. B.S. Molecular and Medical Microbiology.
Our Advisors
HAO LI
PhD, Co-founder & UCSF Professor
JOHN BAMFORTH
PhD, Former CMO at Eli Lilly
BRENT SAUNDERS
CEO Bausch + Lomb
REZA ABBASI ASL
PhD, UCSF Professor, Boinformatics & AI, Weill Institute for Neurosciences
HOLGER WILLENBRING
MD/PhD, UCSF Professor, Director of UCSF Liver Center
JOHN NEWMAN
MD/PhD, Geriatrician and Professor of Metabolism at UCSF and The Buck Institute for Research on Aging
SAMUEL KLEIN
MD, Wash U Professor, Diabetes Research Center
AIMEE KAO
MD/PhD, UCSF Professor, Neurology, Memory & Aging Center
SCOTT FRIEDMAN
MD, Director, Mount Sinai Liver Research Institute
Our Investors
Junevity’s investors include Goldcrest Capital (lead), Godfrey Capital (lead), biotech veterans, doctors, tech entrepreneurs and hedge fund managers.
Global spend on healthcare due to age-related diseases exceeds $5 trillion annually. We can change this.
